JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Extended treatment for venous thromboembolism: how long is long enough?

The long-term aim of treatment of venous thromboembolism (VTE) is the prevention of late recurrences and the post-thrombotic syndrome. The optimal duration of oral anticoagulant therapy after VTE is still controversial. Patients are currently stratified into risk categories for recurrence on the basis of clinical characteristics of the index VTE event. Patients with distal VTE or VTE caused by a transient risk factor are at low risk for recurrence and short-term anticoagulation (3 months) is indicated. Patients with an idiopathic event or with known thrombophilic defects such as factor V Leiden or the G20210A prothrombin mutation are candidates to a longer course of therapy (6 months). Patients with cancer, antiphospholipid antibodies syndrome, recurrent idiopathic event, antithrombin deficiency, protein C or protein S deficiency, homozygosity for factor V Leiden, or double heterozygosity are candidates for extended long-term anticoagulation. More recently, studies have indicated that other factors such as D-dimer levels after the discontinuation of oral anticoagulant therapy or the residual vein thrombosis could be additional predictive factors for recurrences.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app